Literature DB >> 25692918

High-density lipoprotein cholesterol: origins and the path ahead.

Michael N Oda1.   

Abstract

PURPOSE OF REVIEW: We provide a historical perspective of how high-density lipoprotein (HDL) cholesterol became a clinical standard, the evidence in favor of HDL function as a more appropriate indication of HDL's antiatherogenic nature, and the options ahead. RECENT
FINDINGS: Recent studies have demonstrated a strong relationship between the cholesterol efflux capacity of plasma and prevalent cardiovascular disease (CVD) and CVD event risk, indicating the utility of HDL function as a diagnostic/prognostic of CVD.
SUMMARY: We will present how HDL cholesterol came to be the standard proxy of HDL function, the key observations that drew its clinical relevance into question, and the pros and cons of commercially available approaches to measuring HDL function.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25692918     DOI: 10.1097/MED.0000000000000139

Source DB:  PubMed          Journal:  Curr Opin Endocrinol Diabetes Obes        ISSN: 1752-296X            Impact factor:   3.243


  5 in total

1.  Increased high-density lipoprotein cholesterol levels in mice with XX versus XY sex chromosomes.

Authors:  Jenny C Link; Xuqi Chen; Christopher Prien; Mark S Borja; Bradley Hammerson; Michael N Oda; Arthur P Arnold; Karen Reue
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-06-25       Impact factor: 8.311

2.  The association between the DNAH11 rs10248618 SNP and serum lipid traits, the risk of coronary artery disease, and ischemic stroke.

Authors:  Yong-Gang Zhou; Rui-Xing Yin; Jie Wu; Qing-Hui Zhang; Wu-Xian Chen; Xiao-Li Cao
Journal:  Int J Clin Exp Pathol       Date:  2018-09-01

3.  Reduced HDL function in children and young adults with type 1 diabetes.

Authors:  Martin Heier; Mark S Borja; Cathrine Brunborg; Ingebjørg Seljeflot; Hanna Dis Margeirsdottir; Kristian F Hanssen; Knut Dahl-Jørgensen; Michael N Oda
Journal:  Cardiovasc Diabetol       Date:  2017-07-06       Impact factor: 9.951

4.  Lipid Biomarkers as Predictors of Diastolic Dysfunction in Diabetes with Poor Glycemic Control.

Authors:  Dina Khedr; Mona Hafez; Jairo Lumpuy-Castillo; Soha Emam; Antoine Abdel-Massih; Fatma Elmougy; Rasha Elkaffas; Ignacio Mahillo-Fernández; Oscar Lorenzo; Noha Musa
Journal:  Int J Mol Sci       Date:  2020-07-18       Impact factor: 5.923

5.  Sustained Focal Vascular Inflammation Accelerates Atherosclerosis in Remote Arteries.

Authors:  Begoña Lavin Plaza; Alkystis Phinikaridou; Marcelo E Andia; Myles Potter; Silvia Lorrio; Imran Rashid; Rene M Botnar
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-07-16       Impact factor: 8.311

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.